ECM Weekly (17 January 2021) - RLX Tech, Kuaishou, PTT Retail, MicroPort CardioFlow, New Horizon
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.
529 Views
MicroPort Cardioflow (微创心通) Pre-IPO: Strong Sales Ramp-Up Despite Being Late in Market
The company's first-generation TAVR, VitaFlow, has decent clinical data in terms of efficacy and safety. It was launched two years behind VenusA...
399 Views
ECM Weekly (10 January 2021) - RLX Technology, Roiserv, Yidu Tech, and Placements
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.
381 Views
Microport Cardioflow: Winning in TAVR
We provide our initial thoughts on the proposed listing of medical device (TAVR) company MicroPort Cardioflow on the HKEX.
364 Views
Pre-IPO MicroPort CardioFlow - A Better Candidate of the TAVR Market in China?
This article analyzed the market potential of TAVR in China, competition pattern of key players, financial position of MicroPort CardioFlow and...
419 Views